We are live on ! Find out more
JJ

Johnson & Johnson Portfolio holdings

AUM $652M
1-Year Est. Return 198.07%
This Fund
S&P 500
This Quarter Est. Return
+16.03%
1 Year Est. Return
+198.07%
3 Year Est. Return
+299.99%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$555M
AUM Growth
+$51.1M
Cap. Flow
-$9.33M
Cap. Flow %
-1.68%
Top 10 Hldgs %
98.34%
Holding
20
New
–
Increased
–
Reduced
2
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ARWR icon
Arrowhead Research
ARWR
+$8.54M
2
CVRX icon
CVRx
CVRX
+$717K
3
PHGE icon
BiomX
PHGE
+$50.9K
4
SENS icon
Senseonics Holdings Inc
SENS
+$23.8K
5
ACET icon
Adicet Bio
ACET
+$11

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTGX icon
1
Protagonist Therapeutics
PTGX
$9.06B
$214M 38.54%
2,449,183
– –
NBTX
2
Nanobiotix
NBTX
$1.92B
$130M 23.43%
5,623,816
– –
RAPP
3
Rapport Therapeutics
RAPP
$2.04B
$54.1M 9.75%
1,784,517
– –
MGTX icon
4
MeiraGTx Holdings
MGTX
$1.15B
$52.8M 9.51%
6,641,064
– –
CVRX icon
5
CVRx
CVRX
$130M
$28.6M 5.15%
4,024,861
-78,569
-2% -$717K
CTNM
6
Contineum Therapeutics
CTNM
$532M
$22.6M 4.08%
1,979,173
– –
LEGN icon
7
Legend Biotech
LEGN
$4.31B
$17.7M 3.19%
814,586
– –
XNCR icon
8
Xencor
XNCR
$1.3B
$11.5M 2.06%
748,062
– –
PRCT icon
9
Procept Biorobotics
PRCT
$1.09B
$11.3M 2.03%
357,939
– –
FATE icon
10
Fate Therapeutics
FATE
$324M
$3.32M 0.6%
3,379,064
– –
NMRA icon
11
Neumora Therapeutics
NMRA
$298M
$3.31M 0.6%
1,849,445
– –
RLYB icon
12
Rallybio
RLYB
$87.1M
$2.49M 0.45%
454,545
– –
LYEL icon
13
Lyell Immunopharma
LYEL
$326M
$1.69M 0.3%
54,887
– –
VOR icon
14
Vor Biopharma
VOR
$980M
$703K 0.13%
53,732
– –
NNOX icon
15
Nano X Imaging
NNOX
$78M
$445K 0.08%
158,852
– –
LAB icon
16
Standard BioTools
LAB
$350M
$399K 0.07%
311,967
– –
ACET icon
17
Adicet Bio
ACET
$75.9M
$192K 0.03%
22,779
-1
-0% -$11
ARWR icon
18
Arrowhead Research
ARWR
$10.5B
– –
-247,598
Closed -$8.54M
PHGE icon
19
BiomX
PHGE
$2.16M
– –
-5,098
Closed -$50.9K
SENS icon
20
Senseonics Holdings Inc
SENS
$267M
– –
-2,731
Closed -$23.8K

Similar funds

AG
Alibaba Group Causeway Bay, Hong Kong $653M AUM 16.11% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
FMN
Financial Management Network Mission Viejo, California $653M AUM 17.76% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $653M AUM 88.28% 1-Year Est. Return
RRA
Round Rock Advisors Wilton, Connecticut $654M AUM 22.95% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $651M AUM 15.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Johnson & Johnson's Q4 2025 Portfolio in Review

As of Q4 2025, Johnson & Johnson held 20 positions worth $555M, up 10% from $504M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Johnson & Johnson's Q4 2025 filing shows 2 reduced and 3 closed positions. The largest sale was Arrowhead Research, an estimated $8.54M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Johnson & Johnson's biggest Q4 2025 reduction was CVRx, cutting an estimated $717K.
  • Johnson & Johnson fully exited Arrowhead Research in Q4 2025, selling an estimated $8.54M.
  • Johnson & Johnson's ten largest holdings make up 98% of its $555M portfolio in Q4 2025.
  • Johnson & Johnson opened 0 new positions and closed 3 in Q4 2025.
  • Johnson & Johnson's portfolio value rose 10% quarter-over-quarter to $555M.

Based on Johnson & Johnson's 13F filing for Q4 2025, filed 13 Feb 2026.